查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1788077

癌症疼痛市场报告：2031 年趋势、预测和竞争分析

Cancer Pain Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计全球癌症疼痛市场在2025年至2031年间的复合年增长率将达到5.1%，其中放射线治疗、化疗和荷尔蒙疗法市场将迎来机会。这个市场的主要驱动因素是肿瘤体积增加、对周围组织的压迫，以及癌症扩散到其他器官的增加。

  • 根据 Lucintel 的预测，根据类型，阿片类药物预计在预测期内将出现高速增长。
  • 从应用角度来看，化疗预计将达到最高成长。
  • 按地区划分，预计亚太地区将在预测期内实现最高成长。

这份超过 150 页的综合报告将为您提供宝贵的见解，协助您做出更明智的业务决策。以下是包含部分见解的范例图表：

癌症疼痛市场的新趋势

癌症疼痛市场的新趋势正在塑造治疗方法的开发、交付和获取方式。这些趋势反映出人们对更有效、个人化且更方便的疼痛管理解决方案的需求日益增长。药物研究的创新、技术进步以及患者照护的转变正在推动市场的发展。以下是重塑癌症疼痛管理格局的五个关键趋势。

  • 阿片类药物替代疗法和非药物疗法：人们对阿片类药物依赖性和副作用的担忧日益加剧，导致癌症疼痛管理转向非阿片类药物替代疗法。这些疗法包括加巴喷丁类药物和抗忧郁症等药物疗法，以及针灸、物理治疗和认知行为疗法等非药物疗法。这些疗法旨在有效缓解疼痛，同时避免与阿片类药物相关的风险。
  • 个人化疼痛管理：由于患者的疼痛体验和治疗反应差异很大，个人化疼痛管理正成为一种重要趋势。先进的诊断工具和基因分析技术使临床医生能够根据患者个体需求量身定制治疗方案。个人化治疗有望改善疼痛缓解，最大限度地减少副作用，并为癌症疼痛提供更有针对性、更有效的解决方案。
  • 药物传递创新：新型药物传输系统，例如经皮贴片、缓释性和微胶囊技术，正在彻底改变癌症疼痛管理。这些创新能够持续缓解疼痛，减少频繁服药的需求，并提高患者的便利性。此外，这些先进的系统有助于稳定止痛药的血中浓度，进而提高疗效和患者预后。
  • 安宁疗护日益受到关注：随着全球癌症诊断率的上升，以疼痛管理为核心的安宁疗护也日益受到关注。安宁疗护旨在透过解决患者的身体疼痛、情绪、心理和社会需求来改善其生活品质。医疗保健提供者和政策制定者正在优先发展安宁疗护计画和服务，以满足癌症患者的复杂需求。
  • 转向居家照护：居家照护在癌症疼痛管理领域正蓬勃发展。远端医疗、居家医疗服务和携带式疼痛管理设备的进步，使患者能够在家中接受有效治疗。这一转变缩短了住院时间，降低了医疗成本，使患者在治疗期间能够舒适地待在家中，并提高了患者的整体满意度和生活品质。

这些趋势正在重塑癌症疼痛市场，提供更多样化和个人化的解决方案。阿片类药物的替代、药物传输技术的进步以及对整体护理的重视，正在改善患者的治疗效果和满意度。此外，向居家照护和安宁疗护模式的转变也提高了癌症治疗的可近性和可负担性，这对于应对日益增长的全球癌症负担至关重要。

癌症疼痛市场的最新趋势

由于技术进步、创新治疗方法和不断发展的医疗政策，癌症疼痛市场正在经历重大变化。这些发展正在增强癌痛管理，并扩大有效治疗的可近性。以下是影响癌症疼痛市场成长和发展方向的五个关键发展：

  • 非鸦片类疼痛管理方案的发展：随着人们对鸦片类药物使用相关风险的认识不断提高，非鸦片类疼痛管理方案的发展也随之推进。这些替代方案，包括神经阻断疗法、神经生长因子抑制剂和大麻素，能够有效缓解疼痛，且副作用更少。这些方案的转变有望降低癌症患者对鸦片类药物的依赖，并改善其整体疼痛管理。
  • 疼痛管理设备的进步：技术创新推动了神经刺激器和脊髓刺激设备等先进疼痛管理设备的研发。这些设备正被用于治疗顽固性癌痛，为患者提供超越传统药物治疗的选择。这些设备的广泛普及有助于实现个人化的疼痛管理方法。
  • 疼痛管理可近性的监管改进：包括美国和欧洲在内的多个地区正在实施监管改革，以改善癌症疼痛管理解决方案的可及性。旨在扩大阿片类药物可及性、核准新型非阿片类治疗方法以及加强报销体系的政策，正在帮助患者更轻鬆地获得所需的治疗。
  • 联合治疗的创新：药物和非药物干预相结合的联合治疗日益流行。这些治疗方法能够解决癌痛的多个方面，为患者提供更全面的治疗选择。例如，将鸦片类药物与针灸或物理治疗结合，可以增强疼痛缓解效果，改善生活品质。
  • 远端医疗与疼痛管理的整合：远端医疗正在改变癌症疼痛管理，使医疗服务提供者能够远端监控患者并即时调整治疗方案。这项发展尤其有利于农村和服务欠缺地区的患者，使疼痛管理更加便利。远端医疗整合也能提高病患的参与度和治疗顺从性。

这些关键进展透过提供更有效、个人化且更便利的治疗方法，正在改善癌症疼痛管理的前景。因此，患者的疼痛得到更好的缓解，生活品质得到改善，医疗保健系统也受益于更具成本效益的解决方案。

目录

第一章执行摘要

第二章全球癌症疼痛市场：市场动态

  • 简介、背景和分类
  • 供应链
  • PESTLE分析
  • 专利分析
  • 法规环境
  • 产业驱动力与挑战

第三章 2019年至2031年市场趋势及预测分析

  • 宏观经济趋势（2019-2024）及预测（2025-2031）
  • 全球癌症疼痛市场趋势（2019-2024）及预测（2025-2031）
  • 全球癌症疼痛市场（按类型）
    • 阿片类药物：趋势与预测（2019-2031）
    • 非类固醇消炎剂：趋势与预测（2019-2031）
    • 其他：趋势与预测（2019-2031）
  • 全球癌症疼痛市场（按应用）
    • 放射治疗：趋势与预测（2019-2031）
    • 化疗：趋势与预测（2019-2031）
    • 荷尔蒙疗法：趋势与预测（2019-2031）
    • 其他：趋势与预测（2019-2031）

第四章2019年至2031年区域市场趋势与预测分析

  • 全球癌症疼痛市场（按地区）
  • 北美癌症疼痛市场
  • 欧洲癌症疼痛市场
  • 亚太地区癌症疼痛市场
  • 其他地区癌症疼痛市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析
    • 竞争对手之间的竞争
    • 买方的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 新进入者的威胁

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球癌症疼痛市场按类型分類的成长机会
    • 全球癌症疼痛市场的成长机会（按应用）
    • 全球癌症疼痛市场各区域成长机会
  • 全球癌症疼痛市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球癌症疼痛市场容量
    • 全球癌症疼痛市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业公司简介

  • BioDelivery Science
  • ProStrakan Group
  • Teva Pharmaceuticals
  • Eli-Lilly
  • Grunenthal Group
  • GW Pharmaceuticals
  • Johnson&Johnson
  • Meda Pharmaceuticals
  • Orexo
  • Sanofi

The future of the global cancer pain market looks promising with opportunities in the radiotherapy, chemotherapy, and hormone therapy markets. The global cancer pain market is expected to grow with a CAGR of 5.1% from 2025 to 2031. The major drivers for this market are increase in tumor size and pressure on surrounding tissues and the rising spread of cancer to other organs causes.

  • Lucintel forecasts that, within the type category, opioids are expected to witness higher growth over the forecast period.
  • Within the application category, chemotherapy is expected to witness the highest growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Cancer Pain Market

Emerging trends in the cancer pain market are shaping the way treatments are developed, delivered, and accessed. These trends reflect the growing need for more effective, personalized, and accessible pain management solutions. Innovations in pharmaceutical research, technological advancements, and shifts in patient care are driving the evolution of the market. Below are five key trends that are transforming the landscape of cancer pain management.

  • Opioid Alternatives and Non-Pharmacological Therapies: With growing concerns about opioid dependence and side effects, there is an increasing shift towards non-opioid alternatives for cancer pain management. These include medications such as gabapentinoids and anti-depressants, as well as non-pharmacological approaches like acupuncture, physiotherapy, and cognitive-behavioral therapy. These treatments aim to provide effective pain relief without the risks associated with opioids.
  • Personalized Pain Management: Personalized pain management is becoming a significant trend, as patients' pain experiences and responses to treatments vary greatly. Advanced diagnostic tools and genetic profiling are enabling clinicians to tailor treatments based on individual needs. Personalized approaches are expected to improve pain relief and minimize side effects, offering more targeted and effective solutions for cancer pain.
  • Technological Innovations in Drug Delivery: New drug delivery systems, such as transdermal patches, slow-release formulations, and microencapsulation technologies, are revolutionizing cancer pain management. These innovations allow for continuous pain relief, reducing the need for frequent dosing and enhancing patient convenience. Furthermore, these advanced systems can help maintain stable blood levels of pain relief medications, improving efficacy and patient outcomes.
  • Growing Palliative Care Focus: As cancer diagnoses increase globally, there is an expanding focus on palliative care, which includes pain management as a core component. Palliative care aims to improve the quality of life for patients by addressing not only physical pain but also emotional, psychological, and social needs. Healthcare providers and policymakers are prioritizing the development of palliative care programs and services to address the complex needs of cancer patients.
  • Shift toward Home-based Care: Home-based care is gaining momentum in cancer pain management. Advances in telemedicine, home healthcare services, and portable pain management devices are enabling patients to receive effective treatment in their homes. This shift reduces hospital stays, lowers healthcare costs, and provides patients with the comfort of being at home during their treatment, improving overall patient satisfaction and quality of life.

These trends are reshaping the cancer pain market by offering more diversified and personalized solutions. The move away from opioids, advancements in drug delivery technologies, and the focus on holistic care are improving patient outcomes and satisfaction. Additionally, the shift to home-based and palliative care models is increasing accessibility and affordability, which is crucial for addressing the growing global cancer burden.

Recent Developments in the Cancer Pain Market

The cancer pain market is undergoing significant changes driven by technological advancements, innovative therapies, and evolving healthcare policies. These developments are enhancing the management of cancer pain and expanding access to effective treatments. Below are five key developments in the cancer pain market that are influencing its growth and direction.

  • Development of Non-Opioid Pain Management Options: The increasing awareness of the risks associated with opioid use has led to the development of non-opioid pain management alternatives. These alternatives include nerve block treatments, nerve growth factor inhibitors, and cannabinoids, offering effective pain relief with fewer side effects. The shift to these options is expected to reduce opioid dependence and improve overall pain management for cancer patients.
  • Advancements in Pain Management Devices: Technological innovations have resulted in the development of advanced pain management devices, such as neurostimulation and spinal cord stimulators. These devices are being used to treat refractory cancer pain and offer patients more options beyond traditional drug therapies. The growing popularity of these devices is contributing to a more personalized approach to pain management.
  • Regulatory Improvements in Pain Management Access: In several regions, including the United States and Europe, regulatory changes are being implemented to improve access to cancer pain management solutions. Policies focusing on expanding opioid access, approving new non-opioid therapies, and enhancing reimbursement mechanisms are making it easier for patients to access the treatments they need.
  • Innovations in Combination Therapies: The trend toward combination therapies, which combine pharmacological treatments with non-pharmacological interventions, is gaining momentum. These therapies address multiple aspects of cancer pain and provide patients with more comprehensive treatment options. For example, combining opioid medications with acupuncture or physical therapy can enhance pain relief and improve quality of life.
  • Integration of Telemedicine in Pain Management: Telemedicine is transforming cancer pain management by allowing healthcare providers to monitor patients remotely and provide real-time adjustments to treatment plans. This development is particularly beneficial for patients in rural or underserved areas, making pain management more accessible. The integration of telemedicine also improves patient engagement and compliance with treatment regimens.

These key developments are enhancing the cancer pain management landscape by providing more effective, personalized, and accessible treatment options. As a result, patients are experiencing better pain relief and improved quality of life, while healthcare systems benefit from more cost-effective solutions.

Strategic Growth Opportunities in the Cancer Pain Market

The cancer pain market offers significant growth opportunities, particularly in response to the growing global incidence of cancer and the evolving needs of patients. Key applications such as pharmaceuticals, medical devices, and palliative care are critical areas where strategic growth can be achieved. Below are five key growth opportunities by application that are shaping the future of cancer pain management.

  • Pharmaceutical Advancements: The development of new pain-relief medications, particularly non-opioid analgesics, presents significant growth opportunities. With increasing concerns over opioid misuse, pharmaceutical companies are focusing on alternatives such as cannabinoids, anti-depressants, and local anesthetics. Innovations in these medications could provide more effective and safer options for managing cancer pain.
  • Medical Devices for Pain Management: The medical devices segment, including transdermal drug delivery systems, neurostimulation, and implantable pumps, is seeing rapid growth. These devices allow for targeted pain relief, reducing side effects and improving patient quality of life. As technology improves, there will be further opportunities to develop more efficient and user-friendly devices for cancer pain management.
  • Palliative Care Programs: With the rising demand for compassionate care, there is a growing opportunity to develop comprehensive palliative care programs. These programs not only focus on pain management but also address the emotional, psychological, and spiritual needs of cancer patients. Investment in such programs can help healthcare providers offer holistic care, improving patient outcomes and satisfaction.
  • Telemedicine and Home Care Solutions: The expansion of telemedicine and home-based care services presents an opportunity to reach more patients with cancer pain, especially those in remote or underserved areas. By offering remote consultations and monitoring, healthcare providers can deliver continuous care, ensuring timely adjustments to pain management treatments.
  • Oncology-focused Pain Clinics: Specialized oncology pain clinics are emerging as a key opportunity for growth. These clinics provide expert, multi-disciplinary care to cancer patients suffering from pain, offering tailored treatments that address the complexity of cancer pain. The rise in such specialized clinics is an important trend in providing comprehensive care.

These growth opportunities are reshaping the cancer pain market by enhancing access to more personalized, effective, and holistic treatment options. The focus on innovation in drugs, devices, palliative care, and telemedicine is improving patient outcomes and satisfaction while opening new avenues for market expansion.

Cancer Pain Market Driver and Challenges

The cancer pain market is driven by a variety of technological, economic, and regulatory factors, but it also faces several challenges that impact its growth. Understanding the key drivers and challenges is crucial for stakeholders in the healthcare industry to navigate and capitalize on market opportunities. Below are the main drivers and challenges impacting the cancer pain market.

The factors responsible for driving the cancer pain market include:

1. Technological Advancements: New technologies in drug delivery systems, pain management devices, and diagnostic tools are transforming the cancer pain market. Innovations such as personalized pain management and neurostimulation devices are driving market growth by providing more targeted and effective treatments for cancer pain.

2. Increasing Cancer Prevalence: The rising global incidence of cancer is a major driver of the cancer pain market. As the number of cancer patients increases, so does the demand for pain management solutions. This trend is particularly prominent in aging populations, where cancer-related pain management becomes an even more critical need.

3. Opioid Crisis and Shift to Non-Opioid Alternatives: The growing concerns over opioid misuse and addiction are driving the demand for non-opioid alternatives for cancer pain relief. This shift is encouraging research and development in non-opioid medications, as well as alternative pain management therapies such as nerve blocks and acupuncture.

4. Healthcare System Advancements: Improvements in healthcare infrastructure and cancer care policies in both developed and emerging markets are enabling better access to cancer pain management solutions. This includes better insurance coverage, reimbursement policies, and government support for cancer care services.

5. Rising Patient Awareness and Demand for Better Pain Management: Increased awareness among patients and healthcare providers about the importance of managing cancer pain has led to higher demand for effective treatments. This demand is driving innovation in pain management strategies and fueling market growth.

Challenges in the cancer pain market are:

1. Access to Opioids and Pain Management in Developing Regions: Limited access to opioids and other pain management therapies in developing regions remains a significant challenge. Regulatory restrictions, supply chain issues, and cultural stigmas around pain management hinder the ability of patients in these regions to receive adequate care.

2. High Treatment Costs: The high cost of advanced pain management therapies, including certain medications and medical devices, remains a barrier for many patients, especially in low-income and middle-income countries. This limits the affordability and accessibility of effective cancer pain treatments.

3. Lack of Awareness in Rural Areas: In many parts of the world, particularly rural areas, there is a lack of awareness about cancer pain management options. This results in underdiagnosis and undertreatment of cancer pain, negatively impacting patient outcomes.

The cancer pain market is experiencing rapid growth driven by technological innovations, increasing cancer prevalence, and the shift toward non-opioid pain management. However, challenges such as access to treatments in developing regions, high treatment costs, and lack of awareness remain key barriers to market expansion. Addressing these challenges will be crucial for ensuring that cancer patients worldwide receive effective pain management.

List of Cancer Pain Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cancer pain companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cancer pain companies profiled in this report include-

  • BioDelivery Science
  • ProStrakan Group
  • Teva Pharmaceuticals
  • Eli-Lilly
  • Grunenthal Group
  • GW Pharmaceuticals
  • Johnson&Johnson
  • Meda Pharmaceuticals
  • Orexo
  • Sanofi

Cancer Pain Market by Segment

The study includes a forecast for the global cancer pain market by type, application, and region.

Cancer Pain Market by Type [Value from 2019 to 2031]:

  • Opioids
  • Non-Steroidal Anti-Inflammatory Drugs
  • Others

Cancer Pain Market by Application [Value from 2019 to 2031]:

  • Radiotherapy
  • Chemotherapy
  • Hormone Therapy
  • Others

Cancer Pain Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Cancer Pain Market

Cancer pain is a significant issue for cancer patients worldwide, with many facing both acute and chronic pain as a result of the disease and its treatments. The market for cancer pain management includes various therapies, including pharmaceutical options, medical devices, and alternative treatments. Over the years, advancements in drug formulations, the introduction of innovative therapies, and the growing awareness around cancer pain management have propelled the market forward. This document explores the key recent developments, emerging trends, growth opportunities, and the drivers and challenges affecting the cancer pain market in different regions, including the United States, China, Germany, India, and Japan.

  • United States: The United States has seen significant advancements in the cancer pain market, with increased adoption of new drug formulations and the development of innovative pain management technologies. Key players in the pharmaceutical sector are focusing on improving opioid alternatives to address both efficacy and safety concerns. Non-opioid pain management strategies, such as the use of cannabinoids, nerve blocks, and personalized treatments, are gaining traction. Additionally, regulatory efforts and reimbursement policies have improved access to pain relief for cancer patients, fostering market growth.
  • China: The Chinese cancer pain market is experiencing rapid growth, driven by the country's increasing cancer incidence and healthcare advancements. New analgesic drugs, particularly opioid and non-opioid alternatives, are becoming more widely available. The government's focus on improving healthcare infrastructure and enhancing cancer care services is helping address pain management needs. However, there are still challenges in reaching underserved rural areas and overcoming cultural stigmas surrounding pain management. Overall, the Chinese market is witnessing a growing demand for pain relief solutions as awareness of cancer pain treatment expands.
  • Germany: The German cancer pain market is characterized by high-quality healthcare services and the widespread adoption of advanced treatment options. The country has seen a rise in the use of multi-modal pain management strategies, including pharmacological and non-pharmacological treatments. The increasing preference for targeted therapies and combination therapies for cancer pain has influenced market growth. The government's strong regulatory frameworks and comprehensive insurance systems have also helped improve access to pain management services, contributing to the overall growth of the market.
  • India: The Indian cancer pain market is evolving due to a rising cancer burden and improved healthcare access, especially in urban areas. While the market faces challenges such as opioid access restrictions and insufficient awareness, there have been notable advancements in pain management through the use of non-opioid alternatives, such as nerve blocks and palliative care programs. The development of low-cost generic analgesics is helping make cancer pain management more affordable. Furthermore, increased focus on healthcare policy reforms and infrastructure improvements is expected to accelerate the growth of the market in India.
  • Japan: Japan is witnessing steady growth in the cancer pain management market, driven by the aging population and advancements in medical technology. There is a strong focus on improving personalized cancer care, with new drug delivery systems, including slow-release formulations, being developed for long-term pain management. The government is also investing in expanding palliative care services and supporting research into alternative pain management options, such as non-pharmacological therapies. The Japanese market's growth is also fueled by an increased public and healthcare provider awareness about cancer pain.

Features of the Global Cancer Pain Market

  • Market Size Estimates: Cancer pain market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Cancer pain market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Cancer pain market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the cancer pain market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cancer pain market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cancer pain market by type (opioids, non-steroidal anti-inflammatory drugs, and others), application (radiotherapy, chemotherapy, hormone therapy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cancer Pain Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: PESTLE Analysis
  • 2.4: Patent Analysis
  • 2.5: Regulatory Environment
  • 2.6: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Cancer Pain Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Cancer Pain Market by Type
    • 3.3.1: Opioids: Trends and Forecast (2019 to 2031)
    • 3.3.2: Non-Steroidal Anti-Inflammatory Drugs: Trends and Forecast (2019 to 2031)
    • 3.3.3: Others: Trends and Forecast (2019 to 2031)
  • 3.4: Global Cancer Pain Market by Application
    • 3.4.1: Radiotherapy: Trends and Forecast (2019 to 2031)
    • 3.4.2: Chemotherapy: Trends and Forecast (2019 to 2031)
    • 3.4.3: Hormone Therapy: Trends and Forecast (2019 to 2031)
    • 3.4.4: Others: Trends and Forecast (2019 to 2031)

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Cancer Pain Market by Region
  • 4.2: North American Cancer Pain Market
    • 4.2.1: North American Market by Type: Opioids, Non-Steroidal Anti-Inflammatory Drugs, and Others
    • 4.2.2: North American Market by Application: Radiotherapy, Chemotherapy, Hormone Therapy, and Others
    • 4.2.3: The United States Cancer Pain Market
    • 4.2.4: Mexican Cancer Pain Market
    • 4.2.5: Canadian Cancer Pain Market
  • 4.3: European Cancer Pain Market
    • 4.3.1: European Market by Type: Opioids, Non-Steroidal Anti-Inflammatory Drugs, and Others
    • 4.3.2: European Market by Application: Radiotherapy, Chemotherapy, Hormone Therapy, and Others
    • 4.3.3: German Cancer Pain Market
    • 4.3.4: French Cancer Pain Market
    • 4.3.5: Spanish Cancer Pain Market
    • 4.3.6: Italian Cancer Pain Market
    • 4.3.7: The United Kingdom Cancer Pain Market
  • 4.4: APAC Cancer Pain Market
    • 4.4.1: APAC Market by Type: Opioids, Non-Steroidal Anti-Inflammatory Drugs, and Others
    • 4.4.2: APAC Market by Application: Radiotherapy, Chemotherapy, Hormone Therapy, and Others
    • 4.4.3: Japanese Cancer Pain Market
    • 4.4.4: Indian Cancer Pain Market
    • 4.4.5: Chinese Cancer Pain Market
    • 4.4.6: South Korean Cancer Pain Market
    • 4.4.7: Indonesian Cancer Pain Market
  • 4.5: ROW Cancer Pain Market
    • 4.5.1: ROW Market by Type: Opioids, Non-Steroidal Anti-Inflammatory Drugs, and Others
    • 4.5.2: ROW Market by Application: Radiotherapy, Chemotherapy, Hormone Therapy, and Others
    • 4.5.3: Middle Eastern Cancer Pain Market
    • 4.5.4: South American Cancer Pain Market
    • 4.5.5: African Cancer Pain Market

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cancer Pain Market by Type
    • 6.1.2: Growth Opportunities for the Global Cancer Pain Market by Application
    • 6.1.3: Growth Opportunities for the Global Cancer Pain Market by Region
  • 6.2: Emerging Trends in the Global Cancer Pain Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cancer Pain Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cancer Pain Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: BioDelivery Science
    • Company Overview
    • Cancer Pain Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.2: ProStrakan Group
    • Company Overview
    • Cancer Pain Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.3: Teva Pharmaceuticals
    • Company Overview
    • Cancer Pain Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.4: Eli-Lilly
    • Company Overview
    • Cancer Pain Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.5: Grunenthal Group
    • Company Overview
    • Cancer Pain Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.6: GW Pharmaceuticals
    • Company Overview
    • Cancer Pain Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.7: Johnson&Johnson
    • Company Overview
    • Cancer Pain Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.8: Meda Pharmaceuticals
    • Company Overview
    • Cancer Pain Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.9: Orexo
    • Company Overview
    • Cancer Pain Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 7.10: Sanofi
    • Company Overview
    • Cancer Pain Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

List of Figures

  • Figure 2.1: Classification of the Global Cancer Pain Market
  • Figure 2.2: Supply Chain of the Global Cancer Pain Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Global Cancer Pain Market by Type in 2019, 2024, and 2031 ($Billion)
  • Figure 3.20: Trends of the Global Cancer Pain Market ($B) by Type (2019-2024)
  • Figure 3.21: Forecast for the Global Cancer Pain Market ($B) by Type (2025-2031)
  • Figure 3.22: Trends and Forecast for Opioids in the Global Cancer Pain Market (2019-2031)
  • Figure 3.23: Trends and Forecast for Non-Steroidal Anti-Inflammatory Drugs in the Global Cancer Pain Market (2019-2031)
  • Figure 3.24: Trends and Forecast for Others in the Global Cancer Pain Market (2019-2031)
  • Figure 3.25: Global Cancer Pain Market by Application in 2019, 2024, and 2031 ($Billion)
  • Figure 3.26: Trends of the Global Cancer Pain Market ($B) by Application (2019-2024)
  • Figure 3.27: Forecast for the Global Cancer Pain Market ($B) by Application (2025-2031)
  • Figure 3.28: Trends and Forecast for Radiotherapy in the Global Cancer Pain Market (2019-2031)
  • Figure 3.29: Trends and Forecast for Chemotherapy in the Global Cancer Pain Market (2019-2031)
  • Figure 3.30: Trends and Forecast for Hormone Therapy in the Global Cancer Pain Market (2019-2031)
  • Figure 3.31: Trends and Forecast for Others in the Global Cancer Pain Market (2019-2031)
  • Figure 4.1: Trends of the Global Cancer Pain Market ($B) by Region (2019-2024)
  • Figure 4.2: Forecast for the Global Cancer Pain Market ($B) by Region (2025-2031)
  • Figure 4.3: Trends and Forecast for the North American Cancer Pain Market (2019-2031)
  • Figure 4.4: North American Cancer Pain Market by Type in 2019, 2024, and 2031 ($Billion)
  • Figure 4.5: Trends of the North American Cancer Pain Market ($B) by Type (2019-2024)
  • Figure 4.6: Forecast for the North American Cancer Pain Market ($B) by Type (2025-2031)
  • Figure 4.7: North American Cancer Pain Market by Application in 2019, 2024, and 2031 ($Billion)
  • Figure 4.8: Trends of the North American Cancer Pain Market ($B) by Application (2019-2024)
  • Figure 4.9: Forecast for the North American Cancer Pain Market ($B) by Application (2025-2031)
  • Figure 4.10: Trends and Forecast for the United States Cancer Pain Market (2019-2031)
  • Figure 4.11: Trends and Forecast for the Mexican Cancer Pain Market (2019-2031)
  • Figure 4.12: Trends and Forecast for the Canadian Cancer Pain Market (2019-2031)
  • Figure 4.13: Trends and Forecast for the European Cancer Pain Market (2019-2031)
  • Figure 4.14: European Cancer Pain Market by Type in 2019, 2024, and 2031 ($Billion)
  • Figure 4.15: Trends of the European Cancer Pain Market ($B) by Type (2019-2024)
  • Figure 4.16: Forecast for the European Cancer Pain Market ($B) by Type (2025-2031)
  • Figure 4.17: European Cancer Pain Market by Application in 2019, 2024, and 2031 ($Billion)
  • Figure 4.18: Trends of the European Cancer Pain Market ($B) by Application (2019-2024)
  • Figure 4.19: Forecast for the European Cancer Pain Market ($B) by Application (2025-2031)
  • Figure 4.20: Trends and Forecast for the German Cancer Pain Market (2019-2031)
  • Figure 4.21: Trends and Forecast for the French Cancer Pain Market (2019-2031)
  • Figure 4.22: Trends and Forecast for the Spanish Cancer Pain Market (2019-2031)
  • Figure 4.23: Trends and Forecast for the Italian Cancer Pain Market (2019-2031)
  • Figure 4.24: Trends and Forecast for the United Kingdom Cancer Pain Market (2019-2031)
  • Figure 4.25: Trends and Forecast for the APAC Cancer Pain Market (2019-2031)
  • Figure 4.26: APAC Cancer Pain Market by Type in 2019, 2024, and 2031 ($Billion)
  • Figure 4.27: Trends of the APAC Cancer Pain Market ($B) by Type (2019-2024)
  • Figure 4.28: Forecast for the APAC Cancer Pain Market ($B) by Type (2025-2031)
  • Figure 4.29: APAC Cancer Pain Market by Application in 2019, 2024, and 2031 ($Billion)
  • Figure 4.30: Trends of the APAC Cancer Pain Market ($B) by Application (2019-2024)
  • Figure 4.31: Forecast for the APAC Cancer Pain Market ($B) by Application (2025-2031)
  • Figure 4.32: Trends and Forecast for the Japanese Cancer Pain Market (2019-2031)
  • Figure 4.33: Trends and Forecast for the Indian Cancer Pain Market (2019-2031)
  • Figure 4.34: Trends and Forecast for the Chinese Cancer Pain Market (2019-2031)
  • Figure 4.35: Trends and Forecast for the South Korean Cancer Pain Market (2019-2031)
  • Figure 4.36: Trends and Forecast for the Indonesian Cancer Pain Market (2019-2031)
  • Figure 4.37: Trends and Forecast for the ROW Cancer Pain Market (2019-2031)
  • Figure 4.38: ROW Cancer Pain Market by Type in 2019, 2024, and 2031 ($Billion)
  • Figure 4.39: Trends of the ROW Cancer Pain Market ($B) by Type (2019-2024)
  • Figure 4.40: Forecast for the ROW Cancer Pain Market ($B) by Type (2025-2031)
  • Figure 4.41: ROW Cancer Pain Market by Application in 2019, 2024, and 2031 ($Billion)
  • Figure 4.42: Trends of the ROW Cancer Pain Market ($B) by Application (2019-2024)
  • Figure 4.43: Forecast for the ROW Cancer Pain Market ($B) by Application (2025-2031)
  • Figure 4.44: Trends and Forecast for the Middle Eastern Cancer Pain Market (2019-2031)
  • Figure 4.45: Trends and Forecast for the South American Cancer Pain Market (2019-2031)
  • Figure 4.46: Trends and Forecast for the African Cancer Pain Market (2019-2031)
  • Figure 5.1: Porter's Five Forces Analysis for the Global Cancer Pain Market
  • Figure 6.1: Growth Opportunities for the Global Cancer Pain Market by Type
  • Figure 6.2: Growth Opportunities for the Global Cancer Pain Market by Application
  • Figure 6.3: Growth Opportunities for the Global Cancer Pain Market by Region
  • Figure 6.4: Emerging Trends in the Global Cancer Pain Market

List of Table

  • Table 1.1: Growth Rate (%, 2019-2024) and CAGR (%, 2025-2031) of the Cancer Pain Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Cancer Pain Market by Region
  • Table 1.3: Global Cancer Pain Market Parameters and Attributes
  • Table 3.1: Trends of the Global Cancer Pain Market (2019-2024)
  • Table 3.2: Forecast for the Global Cancer Pain Market (2025-2031)
  • Table 3.3: Attractiveness Analysis for the Global Cancer Pain Market by Type
  • Table 3.4: Market Size and CAGR of Various Type in the Global Cancer Pain Market (2019-2024)
  • Table 3.5: Market Size and CAGR of Various Type in the Global Cancer Pain Market (2025-2031)
  • Table 3.6: Trends of Opioids in the Global Cancer Pain Market (2019-2024)
  • Table 3.7: Forecast for the Opioids in the Global Cancer Pain Market (2025-2031)
  • Table 3.8: Trends of Non-Steroidal Anti-Inflammatory Drugs in the Global Cancer Pain Market (2019-2024)
  • Table 3.9: Forecast for the Non-Steroidal Anti-Inflammatory Drugs in the Global Cancer Pain Market (2025-2031)
  • Table 3.10: Trends of Others in the Global Cancer Pain Market (2019-2024)
  • Table 3.11: Forecast for the Others in the Global Cancer Pain Market (2025-2031)
  • Table 3.12: Attractiveness Analysis for the Global Cancer Pain Market by Application
  • Table 3.13: Market Size and CAGR of Various Application in the Global Cancer Pain Market (2019-2024)
  • Table 3.14: Market Size and CAGR of Various Application in the Global Cancer Pain Market (2025-2031)
  • Table 3.15: Trends of Radiotherapy in the Global Cancer Pain Market (2019-2024)
  • Table 3.16: Forecast for the Radiotherapy in the Global Cancer Pain Market (2025-2031)
  • Table 3.17: Trends of Chemotherapy in the Global Cancer Pain Market (2019-2024)
  • Table 3.18: Forecast for the Chemotherapy in the Global Cancer Pain Market (2025-2031)
  • Table 3.19: Trends of Hormone Therapy in the Global Cancer Pain Market (2019-2024)
  • Table 3.20: Forecast for the Hormone Therapy in the Global Cancer Pain Market (2025-2031)
  • Table 3.21: Trends of Others in the Global Cancer Pain Market (2019-2024)
  • Table 3.22: Forecast for the Others in the Global Cancer Pain Market (2025-2031)
  • Table 4.1: Market Size and CAGR of Various Regions in the Global Cancer Pain Market (2019-2024)
  • Table 4.2: Market Size and CAGR of Various Regions in the Global Cancer Pain Market (2025-2031)
  • Table 4.3: Trends of the North American Cancer Pain Market (2019-2024)
  • Table 4.4: Forecast for the North American Cancer Pain Market (2025-2031)
  • Table 4.5: Market Size and CAGR of Various Type in the North American Cancer Pain Market (2019-2024)
  • Table 4.6: Market Size and CAGR of Various Type in the North American Cancer Pain Market (2025-2031)
  • Table 4.7: Market Size and CAGR of Various Application in the North American Cancer Pain Market (2019-2024)
  • Table 4.8: Market Size and CAGR of Various Application in the North American Cancer Pain Market (2025-2031)
  • Table 4.9: Trends of the European Cancer Pain Market (2019-2024)
  • Table 4.10: Forecast for the European Cancer Pain Market (2025-2031)
  • Table 4.11: Market Size and CAGR of Various Type in the European Cancer Pain Market (2019-2024)
  • Table 4.12: Market Size and CAGR of Various Type in the European Cancer Pain Market (2025-2031)
  • Table 4.13: Market Size and CAGR of Various Application in the European Cancer Pain Market (2019-2024)
  • Table 4.14: Market Size and CAGR of Various Application in the European Cancer Pain Market (2025-2031)
  • Table 4.15: Trends of the APAC Cancer Pain Market (2019-2024)
  • Table 4.16: Forecast for the APAC Cancer Pain Market (2025-2031)
  • Table 4.17: Market Size and CAGR of Various Type in the APAC Cancer Pain Market (2019-2024)
  • Table 4.18: Market Size and CAGR of Various Type in the APAC Cancer Pain Market (2025-2031)
  • Table 4.19: Market Size and CAGR of Various Application in the APAC Cancer Pain Market (2019-2024)
  • Table 4.20: Market Size and CAGR of Various Application in the APAC Cancer Pain Market (2025-2031)
  • Table 4.21: Trends of the ROW Cancer Pain Market (2019-2024)
  • Table 4.22: Forecast for the ROW Cancer Pain Market (2025-2031)
  • Table 4.23: Market Size and CAGR of Various Type in the ROW Cancer Pain Market (2019-2024)
  • Table 4.24: Market Size and CAGR of Various Type in the ROW Cancer Pain Market (2025-2031)
  • Table 4.25: Market Size and CAGR of Various Application in the ROW Cancer Pain Market (2019-2024)
  • Table 4.26: Market Size and CAGR of Various Application in the ROW Cancer Pain Market (2025-2031)
  • Table 5.1: Market Presence of Major Players in the Global Cancer Pain Market
  • Table 5.2: Operational Integration of the Global Cancer Pain Market
  • Table 6.1: New Product Launch by a Major Cancer Pain Producer (2019-2024)